Related Experiment Video
Updated: May 13, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial appendage closure devices. Their role in 2013
Minerva Cardioangiologica
|March 16, 2013
Summary
Left atrial appendage closure devices offer a promising alternative to warfarin for stroke prevention in atrial fibrillation patients. These devices may reduce bleeding complications associated with traditional anticoagulation therapy.
Area of Science:
- Cardiology
- Medical Devices
- Thrombosis Research
Background:
- Stroke prevention is critical for patients with atrial fibrillation (AF).
- Warfarin is effective but carries risks like bleeding and drug interactions.
- New anticoagulants offer limited bleeding reduction compared to warfarin.
Purpose of the Study:
- To review the current knowledge and status of percutaneous left atrial appendage (LAA) closure.
- To evaluate LAA closure as an alternative to pharmacotherapy for stroke prevention in AF patients.
Main Methods:
- Review of current clinical and preclinical data on LAA closure devices.
- Analysis of randomized trial data, including the WATCHMAN® device.
Main Results:
- Percutaneous LAA closure is a technologically advanced option for AF patients.
- The WATCHMAN® device shows promising randomized data.
- Several other LAA closure devices are in development.
Conclusions:
- LAA closure presents a viable alternative to pharmacotherapy for stroke risk reduction in AF.
- Further research and development are ongoing for various LAA closure devices.
